血液學診斷試劑市場規模、佔有率、成長分析、按產品、按測試、按最終用戶、按地區 - 按行業預測，2024-2031

2022年，血液學診斷試劑的全球市場規模為78億美元，從2023年的82.4億美元成長到2031年的128.5億美元，在預測期內（2024-2031年）預計將以複合年成長率成長。

血液學診斷市場正在快速發展，主要是由於血液疾病的盛行率不斷增加以及對及時、準確的診斷解決方案的需求不斷成長。在自動化血液分析儀和可提高血液檢測速度和準確性的就地檢驗設備等技術進步的推動下，該行業具有巨大的成長潛力。隨著醫療保健專業人員尋求透過早期檢測和量身定做的治療方案來改善患者的治療結果，該市場預計將會成長。然而，成本和對熟練人員的需求等挑戰仍然存在。儘管存在這些障礙，但隨著向個人化醫療的轉變以及醫療保健提供者和研究人員優先考慮有效的血液疾病管理，這一領域為創新和成長提供了重要的機會。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

血液學診斷試劑市場規模：依產品分類

• 市場概況
• 裝置
  • 分析儀
  • 流式細胞儀
• 消耗品
  • 試劑
  • 染色試劑
  • 其他

血液學診斷試劑市場規模：按測試

• 市場概況
• 貧血
• 血紅素疾病
• 白血病/淋巴瘤表現型
• 血液學病理學
• 全血細胞計數
• 其他

血液學診斷試劑市場規模：依最終用戶分類

• 市場概況
• 醫院
• 診斷實驗室
• 其他

血液學診斷試劑市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Sysmex Corporation（Japan）
• Danaher Corporation（USA）
• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Mindray（China）
• Bio-Rad Laboratories（USA）
• Nihon Kohden（Japan）
• Boule Diagnostics（Sweden）
• EKF Diagnostics（UK）
• Horiba（Japan）
• Roche Diagnostics（Switzerland）
• Beckman Coulter（USA）
• Diatron（Hungary）
• Erba Mannheim（Germany）
• Ortho Clinical Diagnostics（US）
• Cellavision（Sweden）
• Drucker Diagnostics（USA）
• Heska Corporation（USA）
• Neomedica（Germany）
• Thermo Fisher Scientific（USA）

結論和建議

Global Hematology Diagnostics Market size was valued at USD 7.8 billion in 2022 and is poised to grow from USD 8.24 billion in 2023 to USD 12.85 billion by 2031, growing at a CAGR of 5.7% during the forecast period (2024-2031).

The hematology diagnostics market is rapidly evolving, primarily due to the increasing incidence of blood disorders and a growing demand for timely and precise diagnostic solutions. This sector offers considerable growth potential, fueled by technological advancements, including automated hematology analyzers and point-of-care testing devices that enhance the speed and accuracy of blood testing. As healthcare professionals seek to improve patient outcomes through early detection and tailored treatment options, the market is poised for expansion. However, challenges such as cost and the need for skilled personnel persist. Despite these hurdles, the ongoing shift towards personalized medicine highlights significant opportunities for innovation and growth within the hematology diagnostics landscape, as providers and researchers prioritize effective blood disorder management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hematology Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hematology Diagnostics Market Segmental Analysis

Global Hematology Diagnostics Market is segmented by product, test, end user and region. Based on product, the market is segmented into instrument and consumables. Based on test, the market is segmented into anemia, hemoglobinopathy, leukemia/lymphoma phenotyping, hematology pathophysiology, complete blood count and others. Based on end user, the market is segmented into hospitals, diagnostics labs and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hematology Diagnostics Market

The global hematology diagnostics market is significantly influenced by the rising incidence of blood disorders, including anemia, leukemia, and hemophilia. As these conditions become more prevalent, the need for precise and timely detection has surged, propelling the demand for advanced hematology diagnostic solutions. Healthcare providers are increasingly prioritizing early diagnosis and effective monitoring of blood-related ailments, leading to a greater consumption of specialized diagnostic tools and technologies. Consequently, this growing awareness and emphasis on blood health create substantial opportunities for industry players to innovate and expand their offerings within the hematology diagnostics sector, ultimately enhancing patient outcomes worldwide.

Restraints in the Global Hematology Diagnostics Market

The Global Hematology Diagnostics market faces several restraints, one significant barrier being the high expense linked to hematology diagnostic instruments and reagents. These elevated costs can hinder market expansion, as the substantial initial investment required, coupled with ongoing maintenance expenses, may deter healthcare facilities from adopting these technologies. This challenge is especially pronounced in economically constrained healthcare environments, where budget limitations restrict access to advanced diagnostic solutions. Consequently, the financial burden posed by these sophisticated instruments can significantly impact their utilization, ultimately stalling growth in the hematology diagnostics sector.

Market Trends of the Global Hematology Diagnostics Market

The Global Hematology Diagnostics market is witnessing a significant trend towards point-of-care testing, driven by the demand for rapid diagnosis and immediate treatment decisions directly at the patient's location. This shift is facilitated by advancements in portable and handheld hematology analyzers, which enhance the convenience and efficiency of testing in primary healthcare settings and emergency rooms. As healthcare providers seek to improve patient outcomes through timely interventions, the adoption of point-of-care solutions is expected to accelerate. This trend not only addresses the growing need for accessible diagnostics but also aligns with the broader movement towards personalized and immediate healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hematology Diagnostics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Instrument
  • Analyzer
  • Flow Cytometers
• Consumables
  • Reagents
  • Stains
  • Others

Global Hematology Diagnostics Market Size by Test & CAGR (2024-2031)

• Market Overview
• Anemia
• Hemoglobinopathy
• Leukemia/Lymphoma Phenotyping
• Hematology Pathophysiology
• Complete Blood Count
• Others

Global Hematology Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Diagnostics Labs
• Others

Global Hematology Diagnostics Market Size & CAGR (2024-2031)

• North America (Product, Test, End User)
  • US
  • Canada
• Europe (Product, Test, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boule Diagnostics (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diatron (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Mannheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellavision (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drucker Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neomedica (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations